Related Experiment Videos
[Intraoperative autotransfusion in extensive orthopedic interventions]
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete
|May 1, 1983
Summary
Intraoperative autotransfusion (IAT) using the Haemonetics Cell Saver significantly reduces the need for donor blood in major orthopedic surgeries. This method lowers homologous erythrocyte transfusions, decreasing risks and improving patient outcomes.
Area of Science:
- Orthopaedic Surgery
- Transfusion Medicine
Context:
- Massive blood loss is a significant risk in major orthopedic operations.
- Alternative autotransfusion methods include preoperative withdrawal and isovolaemic haemodilution.
Purpose:
- To evaluate the efficacy of the Haemonetics Cell Saver for intraoperative autotransfusion (IAT) in orthopedic surgery.
- To quantify the reduction in homologous erythrocyte transfusions and donor blood usage.
Summary:
- The Haemonetics Cell Saver system demonstrated a reduction of 60.5 L of homologous erythrocytes, equivalent to over 300 units.
- Intraoperative donor blood reduction per patient ranged from 68.0% to 94.8%.
- Postoperative donor blood reduction ranged from 55.6% to 66.2%.
Impact:
- Reduced reliance on allogeneic blood transfusions, thereby decreasing the risk of hepatitis transmission.
- Preservation of autologous erythrocyte quality compared to stored donor blood.
- The Haemonetics Cell Saver is recommended for intraoperative autotransfusion in orthopedic procedures due to its benefits.